Your Diet Isn't Working Because It Wasn't Built For Your Genes.

The FTO gene controls a critical appetite-regulation pathway in your brain. It produces a protein that tells your hypothalamus when you’ve eaten enough. When this signaling works properly, you eat, feel satisfied, and move on. Your brain receives the stop signal.

The FTO A allele variant, carried by roughly 45% of people with European ancestry, disrupts this satiety mechanism. Instead of sending a strong “full” signal after eating, your brain keeps broadcasting hunger. People with this variant don’t overeat because they lack willpower; they overeat because their appetite hormones literally aren’t telling them to stop. They also show a genetic preference for high-fat, calorie-dense foods, and their appetite suppression response to volume and fiber is blunted compared to others.

If you carry this variant, you experience constant low-level hunger even after adequate meals. You feel drawn to fatty, calorie-dense foods. Standard portion control feels like starvation because your satiety signals are genuinely weaker. Regular hunger cues don’t shut off the way they do for others. You might notice you can eat a large salad and still be ravenous, but a small serving of nuts satisfies you for hours.

PPARG is the genetic switch that controls whether your fat cells preferentially store fat or release it for energy. The gene codes for a receptor in fat cells that determines how efficiently dietary fat gets stored versus how readily it gets mobilized. It’s essentially your body’s fat-accumulation setting.

The Pro12 PPARG allele, present in roughly 25% of the population, promotes efficient fat storage. Your fat cells are genetically optimized to take incoming dietary fat and store it. This doesn’t mean you’re destined to be overweight; it means your body is naturally efficient at fat storage, which makes low-fat dieting particularly ineffective for you. When you restrict fat intake, your body doesn’t mobilize stored fat readily; instead, it downregulates metabolism and increases hunger. Your fat cells are literally designed to hang onto fat when calories drop.

If you have this variant, you’ve probably noticed that low-fat diets leave you constantly hungry and tired. Your energy crashes. You regain weight quickly after dieting. Higher-fat diets feel dramatically better, and your weight loss is more consistent. You might do well on Mediterranean or low-carb approaches, but terrible on standard low-fat recommendations.

TCF7L2 is a transcription factor that controls insulin secretion and how your body processes glucose. It regulates whether your pancreas releases the right amount of insulin at the right time to keep blood sugar stable. When this works well, you eat carbs, your blood sugar rises, your pancreas releases appropriate insulin, and your metabolism handles it smoothly.

The TCF7L2 T allele, carried by roughly 30% of the population, is the strongest common genetic risk factor for type 2 diabetes. People with this variant have impaired incretin-stimulated insulin secretion, meaning their pancreas doesn’t respond well when the intestines signal that glucose is coming. Your body struggles to keep blood sugar controlled after carbohydrate intake, triggering excessive insulin release and subsequent blood sugar crashes. This creates a cascade: high insulin drives fat storage, the crash creates intense hunger, and the hunger leads to more carb-seeking behavior.

If you carry this variant, you’ve probably noticed that high-carb meals leave you hungry two hours later, that you crave sugar throughout the day, and that lower-carb eating stabilizes your mood and energy. You might have been told you have “insulin resistance” even though your fasting glucose is normal. Standard advice to eat more whole grains makes you feel worse, not better.

The ADRB2 gene codes for a receptor on your fat cells that responds to adrenaline (your fight-or-flight hormone). When you exercise or experience stress, your body releases adrenaline, which binds to ADRB2 receptors and tells fat cells to release stored fat as energy. This is how your body mobilizes fat. When this works efficiently, you exercise and your fat cells readily release triglycerides into the bloodstream to be burned.

The ADRB2 Gln27Glu and Arg16Gly variants, present in roughly 40% of the population, reduce the fat-mobilization response to catecholamines. Your fat cells have a weaker response to adrenaline, which means they don’t release stored fat as readily during exercise or stress. You can exercise consistently and still not see fat loss because the biological signal that tells your fat cells to release energy is dampened. This doesn’t mean exercise is pointless for you; it means the fat-burning mechanism is less efficient.

If you carry these variants, you’ve probably experienced frustration with cardiovascular exercise. You run regularly, you’re not losing weight the way others do, and your trainer seems confused because “everyone loses weight when they exercise.” You might see better results with strength training or high-intensity interval training than steady-state cardio. You may have noticed stress doesn’t help your body burn fat the way it seems to for others.

The MTHFR gene codes for an enzyme that catalyzes methylation reactions. Methylation is a fundamental metabolic process that affects dozens of pathways, including fat metabolism, energy production, detoxification, and even appetite regulation. When MTHFR works efficiently, these processes run smoothly. Your body efficiently processes nutrients, clears metabolic byproducts, and maintains stable energy.

The MTHFR C677T variant, present in roughly 40% of people with European ancestry, reduces enzyme efficiency by 35-50%. This impairs methylation-dependent metabolic processes, including the pathways that control fat oxidation and energy production. Your cells work harder to produce the same amount of energy, and fat metabolism becomes less efficient. You might also have difficulty clearing homocysteine (an amino acid whose accumulation slows metabolism), and your nutrient absorption becomes less efficient because the methylation-dependent steps in nutrient conversion are slowed.

If you carry this variant, you’ve probably noticed chronic low-level fatigue that doesn’t respond to sleep, brain fog that worsens with stress or overwork, and a tendency toward poor recovery even with adequate rest. Weight management feels harder because your baseline metabolic rate is lower. You might struggle with mood regulation or anxiety under stress.

The APOE gene codes for apolipoprotein E, a protein that packages dietary fat and cholesterol into particles that can be transported through your bloodstream. APOE determines how your body handles fat intake, how quickly those fat particles are cleared from circulation, and how your lipid levels respond to dietary changes. There are three variants: E2, E3, and E4, and they have dramatically different fat-handling characteristics.

The APOE E4 allele (present in roughly 25% of the population) impairs fat particle clearance and increases sensitivity to dietary saturated fat. People with E4 see rapid increases in LDL cholesterol and triglycerides when eating high-fat diets, while those with E2 or E3 remain relatively unaffected. If you carry the E4 allele, your body simply cannot handle high dietary fat the way others can without seeing metabolic consequences. E2 carriers, by contrast, clear fat efficiently and often have favorable lipid profiles even on higher-fat diets. E3 is intermediate.

If you carry E4, you’ve probably noticed that high-fat diets worsen your lipid panel despite weight loss. You might have been told you have “familial hypercholesterolemia” or that you’re “sensitive to saturated fat.” Standard ketogenic or paleo approaches that work beautifully for others make your lipid markers worse. Lower-fat approaches make you feel better and see better metabolic outcomes.